Literature DB >> 5298611

Correction of the hemostatic defects in Von Willebrand's disease.

H A Perkins.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 5298611

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  12 in total

1.  The effects of epinephrine infusion in patients with von Willebrand's disease.

Authors:  F R Rickles; L W Hoyer; M E Rick; D J Ahr
Journal:  J Clin Invest       Date:  1976-06       Impact factor: 14.808

2.  Subunit structure of factor VIII antigen synthesized by cultured human endothelial cells.

Authors:  E A Jaffe; R L Nachman
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

3.  Pharmacokinetics and hemostatic effect of different factor VIII/von Willebrand factor concentrates in von Willebrand's disease type III.

Authors:  S Lethagen; E Berntorp; I M Nilsson
Journal:  Ann Hematol       Date:  1992-12       Impact factor: 3.673

4.  Management of intraventricular haemorrhage secondary to ruptured arteriovenous malformation in a child with von Willebrand's disease.

Authors:  R K Osenbach; C M Loftus; A H Menezes; J Biller; R Tannous; W T Yuh
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-12       Impact factor: 10.154

5.  Von Willebrand's disease.

Authors:  P M Aggeler
Journal:  Calif Med       Date:  1969-08

6.  Von Wllebrands disease. Distinction from other syndromes associated with a long bleeding time, and from hemophilia.

Authors: 
Journal:  Calif Med       Date:  1969-08

Review 7.  Platelet von Willebrand factor in inherited and acquired bleeding disorders.

Authors:  P M Mannucci
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

8.  The use of heat-treated Factor VIII-concentrates in von Willebrand's disease.

Authors:  M Köhler; P Hellstern; E Wenzel
Journal:  Blut       Date:  1985-01

9.  Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.

Authors:  H J Weiss; J Rogers; H Brand
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

Review 10.  Current management of von Willebrand's disease.

Authors:  G Castaman; F Rodeghiero
Journal:  Drugs       Date:  1995-10       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.